Global Retirement Partners’s Amicus Therapeutics FOLD Stock Holding History

Global Retirement Partners’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$812	Buy	57 +11	+24%	+$108	﹤0.01%	3922
2025 Q3	$362	Hold	46	–	–	﹤0.01%	3687
2025 Q2	$264	Buy	+46	New	+$297	﹤0.01%	3652
2024 Q4	$433	Hold	46	–	–	﹤0.01%	3425
2024 Q3	$491	Hold	46	–	–	﹤0.01%	3279
2024 Q2	$456	Hold	46	–	–	﹤0.01%	3308
2024 Q1	$542	Hold	46	–	–	﹤0.01%	3118
2023 Q4	$585	Buy	+46	New	+$522	﹤0.01%	3043
2020 Q4	–	Sell	-1,361	Closed	-$19K	–	1755
2020 Q3	$19K	Buy	1,361 +341	+33%	+$4.97K	﹤0.01%	942
2020 Q2	$15K	Buy	1,020 +134	+15%	+$1.63K	﹤0.01%	989
2020 Q1	$8K	Buy	+886	New	+$8.42K	﹤0.01%	1086

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Retirement Partners's FOLD Position: Q4 2025 in Review

Global Retirement Partners increased its Amicus Therapeutics (FOLD) stake by 24% in Q4 2025, buying an estimated $108 and bringing the position to 57 shares worth $812. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Global Retirement Partners first reported a position in FOLD in Q1 2020 and has held it in 11 quarters since. The position peaked at $19K in Q3 2020. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

Global Retirement Partners held 57 shares of Amicus Therapeutics worth $812 as of Q4 2025.
Global Retirement Partners bought 11 Amicus Therapeutics shares in Q4 2025, an estimated $108.
Amicus Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3922 holding.
Global Retirement Partners first reported a position in Amicus Therapeutics in Q1 2020 and has held it in 11 quarters since.
Global Retirement Partners's Amicus Therapeutics position peaked at $19K in Q3 2020.
332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.